Company: BSX
Filing Date: 2025-03-19
Form Type: DEF 14A
Source: 0000885725-25-000017
Chunk: 120

Company: BOSTON SCIENTIFIC CORP
Filing Date: 2025-03-19
Form: DEF 14A
Chunk 120
---
 31, 2024 under the 2023 rTSR PSP and the one-year period from January 1, 2024 through December 31, 2024 under the 2024 rTSR PSP were between target and maximum level of performance under the program. Shares underlying the 2022 FCF performance‐based RSUs have been included at 87.8% of target, the actual number of units for which the performance criteria under the programs have been satisfied. Such units remained subject to the individual service criteria under the program, which were met on December 31, 2024 for the 2022 FCF performance-based RSUs. The 2023 ONSG and 2024 ONSG performance-based RSUs have been included assuming maximum achievement of the plan criteria and achievement of the individual service criteria of the program (200% of the target units awarded). We have included the number of shares underlying the maximum number of units in column (a) for both the 2023 ONSG and 2024 ONSG performance-based RSUs because the Company’s ONSG performance during the two-year period from January 1, 2023 through December 31, 2024 under the 2023 ONSG PSP and one-year period from January 1, 2024 through December 31, 2024 under the 2024 ONSG PSP were between target and maximum level of performance under the program.

(2) This number e xclud es 9,480,318 shar es in the form of service‐based RSUs, Company performance‐based RSUs and restricted stock granted pursuant to our equity plans included in column (a). These awards allow for the distribution of shares to the grant recipient upon vesting and do not have an associated exercise price. Accordingly, these awards are not reflected in the weighted‐average exercise price.

(3) This number includes, as of December 31, 2024, the 46,413,352 sha res available for issuance under our 2011 LTIP and 5,971,085 shar es available for purchase by our employees under our Employee Stock Purchase Plan, which are not available for grant in any other form.

(4) We have acquired a number of companies over the past several years. From time to time, we have assumed the acquired company’s incentive plan(s), including the outstanding stock options and warrants, if any, granted under those plan(s). No further stock options are outstanding under assumed